Overview
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 28 days early.
- 202503/07/2026
- 202430/06/2025
- 202326/06/2024
- 202228/06/2023
- 202129/04/2022
- 202020/09/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Authorized Representatives
Manner of representation
In the case of a multi-member management board, the following are authorized to make declarations of will on behalf of the company: - the President of the Management Board and the Vice-President each independently; - a member of the management board only jointly with the President or the Vice-President of the Management Board.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Małgorzata Teresa Magieraage 71 | 67 | $9,049.16 | 67% |
Tomasz Magieraage 41 | 33 | $4,457.05 | 33% |
Małgorzata Teresa Magiera and Tomasz Magiera hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2002-08-30.
04 1240 6410 1111 0010 6900 0626
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 17,773PLN 17,773 |
Public aid
4 public aid cases recorded, with a total value of $103,047.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $5,209$5,209 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $5,025$5,025 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 23, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $87,285$87,285 | Polski Fundusz Rozwoju S.A. |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| DR ZdrowieS.A. | $40,415,498.47 | drzdrowie.pl | ||
| MagmaxS.A. | $4,200,912.15 | magmaxsa.pl | ||
| Adpharmasp. z o.o. | $4,026,799.19 | adamed.com | ||
| Novopharm - Millersp. j. | $2,839,228.36 | apteka.zyj-zdrowo.com | ||
| MaglowS.A. | $1,356,219.12 | maglow.pl | ||
| Farmacja Im. O. Klimuszkisp. z o.o. | $1,289,548.20 | zyj-zdrowo.com | ||
| Nukloversp. z o.o. | $227,479.26 | nuklover.com | ||
| Massmedsp. z o.o. | $49,747.70 | mojoapps.co | ||
| DR Farm K. Wenda Zakłady Przemysłowo-Handlowe w Warszawie z Siedzibą w WarszawieS.A. | $2,740.83 | kwendasa.pl | ||
| Femaherbsp. z o.o. | $655.76 | femaherb.com |
Change history
| Date | Event | |
|---|---|---|
| 2017-03-13 | Switch to PKD 2007 (11 PKD 2004 codes → 10 PKD 2007 codes) | |
| 2002-08-23 | Entered in the register |
FAQ
Last updated: 2026-07-06